Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Iatreia
Print version ISSN 0121-0793
Abstract
GONZALEZ NARANJO, Luis Alonso; RESTREPO ESCOBAR, Mauricio and VASQUEZ DUQUE, Gloria María. Contraception in women with systemic erythematosus lupus. Iatreia [online]. 2013, vol.26, n.3, pp.313-324. ISSN 0121-0793.
The use of contraceptives, particularly of those containing estrogens by women with systemic lupus erythematosus (SLE), has been thought to carry risks such as disease exacerbation, thrombosis and other adverse effects. However, the available evidence suggests that many women with SLE, particularly those with stable disease, are not at increased risk of disease flare while taking oral contraceptives and therefore can be good candidates for most contraceptive methods, including the hormonal ones. Contrariwise, women with positive antiphospholipid antibodies are at increased risk of arterial and venous thrombosis and therefore the use of combined hormonal contraceptive methods should be avoided in them.
Keywords : Contraception; Systemic Lupus Erythematosus; Thrombosis.